These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation. Afrough A; Saliba RM; Hamdi A; El Fakih R; Varma A; Dinh YT; Rondon G; Cornelison AM; Shah ND; Bashir Q; Shah JJ; Hosing C; Popat U; Orlowski RZ; Champlin RE; Parmar S; Qazilbash MH Biol Blood Marrow Transplant; 2015 Aug; 21(8):1413-7. PubMed ID: 25842049 [TBL] [Abstract][Full Text] [Related]
3. Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial. Huang X; Wang Q; Chen W; Zeng C; Chen Z; Gong D; Zhang H; Liu Z BMC Med; 2014 Jan; 12():2. PubMed ID: 24386911 [TBL] [Abstract][Full Text] [Related]
4. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308 [TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement. Badar T; Cornelison AM; Shah ND; Bashir Q; Parmar S; Patel K; Hosing C; Popat U; Weber DM; Thomas SK; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH Eur J Haematol; 2016 Oct; 97(4):342-7. PubMed ID: 26773409 [TBL] [Abstract][Full Text] [Related]
6. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis. Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744 [TBL] [Abstract][Full Text] [Related]
7. High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases. Tsukada N; Ikeda M; Shingaki S; Miyazaki K; Meshitsuka S; Yoshiki Y; Abe Y; Suzuki K Int J Hematol; 2016 Mar; 103(3):299-305. PubMed ID: 26703787 [TBL] [Abstract][Full Text] [Related]
8. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation. Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413 [TBL] [Abstract][Full Text] [Related]
10. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience. Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891 [TBL] [Abstract][Full Text] [Related]
11. [Therapy options in systemic AL-amyloidosis with renal involvement]. Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911 [TBL] [Abstract][Full Text] [Related]
12. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study. Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis. Matsuda M; Yamada T; Gono T; Shimojima Y; Ishii W; Fushimi T; Sakashita K; Koike K; Ikeda S Intern Med; 2005 May; 44(5):428-33. PubMed ID: 15942088 [TBL] [Abstract][Full Text] [Related]
19. The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation. Leung N; Kumar SK; Glavey SV; Dispenzieri A; Lacy MQ; Buadi FK; Hayman SR; Dingli D; Kapoor P; Zeldenrust SR; Russell SJ; Lust JA; Hogan WJ; Rajkumar SV; Gastineau DA; Kourelis TV; Lin Y; Gonsalves WI; Go RS; Gertz MA Nephrol Dial Transplant; 2016 Aug; 31(8):1284-9. PubMed ID: 26627634 [TBL] [Abstract][Full Text] [Related]
20. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]